New SPAC: Bellevue Life Sciences Files for $60M IPO to Acquire BioTech Business

Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC) filed its S-1 last Friday, representing the tenth and final SPAC to file in April.  Bellevue intends to acquire a business in the biotechnology sector and has an offering size of just $60M. Similar to all but three of the ten SPACs that have filed in April, Beelevue has
Read More